In addition, we showed that oral application of QCSPIONs (25 mg/kg) during 42 consecutive days protects AlCl 3-induced neurotoxicity in a rat model of AD via targeting the APP/miR-101 pathway [255]. The gene discussed is APP; the disease is Alzheimer disease.